Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TNYA Tenaya Therapeutics Inc

Closed Juneteenth National Independence Day 06-18 16:00:00 EDT

0.7306

+0.0191

+2.68%

盘后0.7365

+0.0059+0.81%

19:56 EDT

High0.7400	Low0.6912	Vol2.55M
Open0.7100	D1 Closing0.7115	Amplitude6.86%
Mkt Cap158.18M	Tradable Cap150.39M	Total Shares216.51M
T/O1.83M	T/O Rate1.24%	Tradable Shares205.84M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TNYA","market":"US","secType":"STK","nameCN":"Tenaya Therapeutics Inc","latestPrice":0.7306,"timestamp":1781812800000,"preClose":0.7115,"halted":0,"volume":2551532,"hourTrading":{"tag":"盘后","latestPrice":0.7365,"preClose":0.7306,"latestTime":"19:56 EDT","volume":128441,"amount":94190.219825,"timestamp":1781826970258,"change":0.0059,"changeRate":0.008076,"amplitude":0.041199},"delay":0,"changeRate":0.02684469430780043,"floatShares":205841252,"shares":216505900,"eps":-0.461845,"marketStatus":"Closed Juneteenth National Independence Day","change":0.0191,"latestTime":"06-18 16:00:00 EDT","open":0.71,"high":0.74,"low":0.6912,"amount":1827470.6239702,"amplitude":0.068587,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.461845,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.7115,"preHourTrading":{"tag":"盘前","latestPrice":0.7101,"preClose":0.7115,"latestTime":"09:21 EDT","volume":6499,"amount":4574.87337003,"timestamp":1781788919208,"change":-0.0014,"changeRate":-0.001968,"amplitude":0.041743},"postHourTrading":{"tag":"盘后","latestPrice":0.7365,"preClose":0.7306,"latestTime":"19:56 EDT","volume":128441,"amount":94190.219825,"timestamp":1781826970258,"change":0.0059,"changeRate":0.008076,"amplitude":0.041199},"volumeRatio":0.9872935387344919,"impliedVol":1.4268,"impliedVolPercentile":0.4223},"requestUrl":"/m/hq/s/TNYA","defaultTab":"news","newsList":[{"id":"2641016464","title":"Tenaya Therapeutics posts Jefferies healthcare conference deck on heart disease gene therapy pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2641016464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641016464?lang=en_us&edition=fundamental","pubTime":"2026-06-05 03:23","pubTimestamp":1780601035,"startTime":"0","endTime":"0","summary":"Tenaya highlighted 2026 catalysts to advance TN-201 and TN-401 toward pivotal-study planning, with regulatory endpoint and design updates expected in 2H 2026.TN-201 MyPEAK-1 interim data showed improvement across biomarkers, hypertrophy measures, symptom scores, and functional capacity, with durability out to 2 years in Cohort 1.All evaluable TN-201 patients achieved LVMI reductions; Cohort 2 showed declines as early as week 26, including -21% and -25% in two patients.TN-201 safety profile remained consistent, with mostly mild, transient, reversible adverse events; the most common were asymptomatic liver enzyme elevations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenaya Therapeutics Inc. published the original content used to gen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL977zlw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640184246","title":"Tenaya Therapeutics management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2640184246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640184246?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:45","pubTimestamp":1780519527,"startTime":"0","endTime":"0","summary":"Meeting to be held in New York on June 4 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640186238","title":"Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Tenaya Therapeutics (TNYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640186238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640186238?lang=en_us&edition=fundamental","pubTime":"2026-06-04 02:20","pubTimestamp":1780510843,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cabaletta Bio (CABA) and Tenaya Therapeutics (TNYA) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cabaletta-bio-caba-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cabaletta-bio-caba-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","CABA","HCSG","XBI","BK4539","LU0029874061.USD","BK4588","BK4139","BK4581","LU0128526141.USD","BK4137","XLV","TNYA","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640185440","title":"Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Tenaya Therapeutics (TNYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640185440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640185440?lang=en_us&edition=fundamental","pubTime":"2026-06-04 01:00","pubTimestamp":1780506041,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ligand Pharma (LGND) and Tenaya Therapeutics (TNYA) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","BK4139","IE0009354923.USD","TNYA","LU1559883803.SGD","LGND","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906987","title":"Tenaya Therapeutics - Cohort 1 Benefits Sustained up to Two Years; Cohort 2 Shows Earlier Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906987?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906933","title":"Tenaya Therapeutics - All Evaluable Patients Show Improvements in Mybpc3-Associated HCM After Tn-201 Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906933?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906520","title":"Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment of Mybpc3-Associated HCM With Tn-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906520?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640290640","title":"Tenaya Therapeutics - Tn-201 Well Tolerated With No New Safety Events Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2640290640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640290640?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640143925","title":"Tenaya Therapeutics to release new interim MyPEAK-1 trial data for TN-201 gene therapy in MYBPC3-associated HCM on June 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2640143925","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640143925?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:33","pubTimestamp":1780432400,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics scheduled new interim data from the MyPEAK-1 Phase 1b/2 trial of TN-201 gene therapy for June 3, 2026.Results have not been presented yet; the update will cover Cohort 1 and Cohort 2 in adults with MYBPC3-associated hypertrophic cardiomyopathy.The readout is positioned as an early look at whether TN-201 shows signs of improving disease-related outcomes in this genetic form of HCM.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL59VFPL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","BK4539","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","LU2210149790.SGD","SG9999014005.SGD","BK4585","BK4112","SG9999014021.USD","NDAQ","TNYA","BK4588","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640925992","title":"Tenaya Therapeutics to Announce New Interim Data From Mypeak™-1 Phase 1B/2 Trial of Tn-201 for Adults With Mybpc3-Associated HCM on Wednesday, June 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640925992","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640925992?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:30","pubTimestamp":1780432200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUABSDM8K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TNYA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639608802","title":"Tenaya Therapeutics Shareholders Approve Expanded Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2639608802","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639608802?lang=en_us&edition=fundamental","pubTime":"2026-05-30 06:37","pubTimestamp":1780094248,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Tenaya Therapeutics ( ($TNYA) ). On May 27, 2026, Tenaya Therapeutics’ shareholders approved an amended and res...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-shareholders-approve-expanded-equity-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-shareholders-approve-expanded-equity-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","EQR","BK4539","BK4585","BK4139","TNYA","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639677023","title":"Tenaya Therapeutics shareholders approve amended 2021 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639677023","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639677023?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:05","pubTimestamp":1780088739,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics held its annual shareholder meeting on May 27, 2026.Investors approved an amended and restated 2021 equity incentive plan, effective May 27, 2026, including a one-time increase of 6,509,966 shares.The revised plan also removes the 4 million annual cap on the evergreen increase while keeping the annual increase at 4% of outstanding shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenaya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL3Lcpfn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639410622","title":"Tenaya Therapeutics to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2639410622","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639410622?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:02","pubTimestamp":1780056138,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 at 3:10 p.m. ET.Company executives are also scheduled to participate in the conference, which runs June 2-4, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL1Hs9fH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","SG9999014013.SGD","LU2095319765.USD","BK4539","LU2210149790.SGD","BK4139","SG9999014021.USD","LU0314104364.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4112","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","TNYA","BK4588","BK4585","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636019117","title":"Buy Rating Reiterated on Tenaya: Promising TN-401 RIDGE-1 Data, Strong Transgene Expression, and Upcoming Catalysts Support Attractive Risk/Reward","url":"https://stock-news.laohu8.com/highlight/detail?id=2636019117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636019117?lang=en_us&edition=fundamental","pubTime":"2026-05-18 05:05","pubTimestamp":1779051936,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Michael Ulz has maintained their bullish stance on TNYA stock, giving a Buy rating on May 15. Michael Ulz has given his Buy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-tenaya-promising-tn-401-ridge-1-data-strong-transgene-expression-and-upcoming-catalysts-support-attractive-risk-reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-tenaya-promising-tn-401-ridge-1-data-strong-transgene-expression-and-upcoming-catalysts-support-attractive-risk-reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2347655156.SGD","LU1244550494.USD","LU2111349929.HKD","LU0106831901.USD","BK4139","LU1548497426.USD","LU0390134368.USD","LU2271345857.HKD","LU0098860793.USD","LU1244550221.USD","LU0971096721.USD","LU0528227936.USD","LU1162221912.USD","LU0267386448.USD","LU2023251221.USD","LU0234570918.USD","LU0320765646.SGD","LU1988902786.USD","LU0158827948.USD","LU2089284900.SGD","LU2028103732.USD","LU0795875169.SGD","LU1791710582.SGD","LU2089283258.USD","TNYA","BK4516","LU1244550577.SGD","LU0912757837.SGD","LU1363072403.SGD","IE00BKVL7J92.USD","LU0158827781.USD","LU0557290698.USD","LU0106261372.USD","LU1668664300.SGD","LU2357305700.SGD","LU1074936037.SGD","LU1064131342.USD","BK4127","BK4581","LU0006306889.USD","LU1732799900.SGD","BK4504","LU1791710400.SGD","LU0795875086.SGD","LU0225283273.USD","LU0882574139.USD","LU1720051108.HKD","LU2133065610.SGD","LU1989772840.SGD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635203245","title":"Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Lineage Therap (LCTX) and RenovoRx (RNXT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635203245","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635203245?lang=en_us&edition=fundamental","pubTime":"2026-05-16 03:30","pubTimestamp":1778873420,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tenaya Therapeutics (TNYA), Lineage Therap (LCTX) an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tenaya-therapeutics-tnya-lineage-therap-lctx-and-renovorx-rnxt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tenaya-therapeutics-tnya-lineage-therap-lctx-and-renovorx-rnxt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","BK4139","LU0128526141.USD","XLV","BK4588","LABU","LU0029874061.USD","BK4539","BK4137","TNYA","XBI","LCTX","BK4581","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635603415","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635603415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635603415?lang=en_us&edition=fundamental","pubTime":"2026-05-16 02:40","pubTimestamp":1778870414,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenaya Therapeutics (TNYA) and Wave Life Sciences (W...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-176?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-176?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4137","BK4112","BLSG","LABU","WVE","BK4588","LU0029874061.USD","LU0128526141.USD","BK4139","BLSX","TNYA","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635608036","title":"Analyst Reiterates Buy on Positive TN-401 RIDGE-1 Data Despite Cutting Price Target from $19 to $3","url":"https://stock-news.laohu8.com/highlight/detail?id=2635608036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635608036?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:55","pubTimestamp":1778860519,"startTime":"0","endTime":"0","summary":"Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Tenaya Therapeutics, reducing the price target to $3.00. Cory Jubinville...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-positive-tn-401-ridge-1-data-despite-cutting-price-target-from-19-to-3-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-positive-tn-401-ridge-1-data-despite-cutting-price-target-from-19-to-3-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635862200","title":"Tenaya Shares Rise on Positive Data From ARVC Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2635862200","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635862200?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:14","pubTimestamp":1778843640,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics shares rose after the company reported positive interim data from a trial of its gene therapy to treat arrhythmogenic right ventricular cardiomyopathy.The stock rose 4.8% to 98 cents in premarket trading. It has more than doubled over the past 12 months.The biotechnology company said the Phase 1b/2 trial demonstrated consistent and deep reductions in premature ventricular contractions.Tenaya's chief medical officer, Whit Tingley, said the trial has shown consistent improvements in ventricular electrical stability, which is predicted to \"decrease the risk for more serious, life-threatening arrhythmias.\". The therapy was also well-tolerated at both dose levels in the study, the company said","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tenaya Shares Rise on Positive Data From ARVC Study","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635208364","title":"Tenaya reports data from RIDGE-1 Phase 1b/2 clinical trial of TN-401","url":"https://stock-news.laohu8.com/highlight/detail?id=2635208364","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635208364?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:13","pubTimestamp":1778840037,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics (TNYA) presented interim data from the ongoing RIDGE-1 Phase 1b/2 clinical trial of TN-401 gene therapy at the American Society...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenaya-reports-data-from-ridge-1-phase-1b-2-clinical-trial-of-tn-401-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenaya-reports-data-from-ridge-1-phase-1b-2-clinical-trial-of-tn-401-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635908851","title":"Tenaya Therapeutics Inc - All Patients Achieve Mean 64% Decrease in Daily Pvc Count With Tn-401","url":"https://stock-news.laohu8.com/highlight/detail?id=2635908851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635908851?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:01","pubTimestamp":1778839260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA87YGMK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tenayatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.015},{"period":"1month","weight":-0.0723},{"period":"3month","weight":-0.0274},{"period":"6month","weight":0.043},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.0268}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.091688},{"month":2,"riseRate":0.2,"avgChangeRate":-0.006231},{"month":3,"riseRate":0.4,"avgChangeRate":-0.077091},{"month":4,"riseRate":0.2,"avgChangeRate":0.069395},{"month":5,"riseRate":0.4,"avgChangeRate":0.046898},{"month":6,"riseRate":0.2,"avgChangeRate":-0.08773},{"month":7,"riseRate":0.5,"avgChangeRate":-0.023292},{"month":8,"riseRate":0.4,"avgChangeRate":0.09529},{"month":9,"riseRate":0.4,"avgChangeRate":-0.101393},{"month":10,"riseRate":0.2,"avgChangeRate":-0.046678},{"month":11,"riseRate":0.4,"avgChangeRate":0.123533},{"month":12,"riseRate":0.2,"avgChangeRate":-0.128991}],"exchange":"NASDAQ","name":"Tenaya Therapeutics Inc","nameEN":"Tenaya Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tenaya Therapeutics Inc(TNYA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tenaya Therapeutics Inc,TNYA,Tenaya Therapeutics Inc股票,Tenaya Therapeutics Inc股票老虎,Tenaya Therapeutics Inc股票老虎国际,Tenaya Therapeutics Inc行情,Tenaya Therapeutics Inc股票行情,Tenaya Therapeutics Inc股价,Tenaya Therapeutics Inc股市,Tenaya Therapeutics Inc股票价格,Tenaya Therapeutics Inc股票交易,Tenaya Therapeutics Inc股票购买,Tenaya Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tenaya Therapeutics Inc(TNYA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}